241 related articles for article (PubMed ID: 19575689)
1. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
Jones HE; Chaikummao S; van de Wijgert JH; Friedland BA; Manopaiboon C; Witwatwongwana P; Wankrairot M; Chantharojwong N; Kilmarx PH
J Womens Health (Larchmt); 2009 Jul; 18(7):1003-10. PubMed ID: 19575689
[TBL] [Abstract][Full Text] [Related]
2. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.
Coggins C; Blanchard K; Alvarez F; Brache V; Weisberg E; Kilmarx PH; Lacarra M; Massai R; Mishell D; Salvatierra A; Witwatwongwana P; Elias C; Ellertson C
Sex Transm Infect; 2000 Dec; 76(6):480-3. PubMed ID: 11221133
[TBL] [Abstract][Full Text] [Related]
3. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.
Kilmarx PH; van de Wijgert JH; Chaikummao S; Jones HE; Limpakarnjanarat K; Friedland BA; Karon JM; Manopaiboon C; Srivirojana N; Yanpaisarn S; Supawitkul S; Young NL; Mock PA; Blanchard K; Mastro TD
J Acquir Immune Defic Syndr; 2006 Nov; 43(3):327-34. PubMed ID: 16980907
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of Carraguard vaginal gel use among Thai couples.
Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
6. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
[TBL] [Abstract][Full Text] [Related]
7. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.
Carraguard Phase II South Africa Study Team
Contraception; 2010 Dec; 82(6):563-71. PubMed ID: 21074021
[TBL] [Abstract][Full Text] [Related]
8. Carraguard acceptability among men and women in a couples study in Thailand.
Martin S; Blanchard K; Manopaiboon C; Chaikummao S; Schaffer K; Friedland B; Kilmarx PH
J Womens Health (Larchmt); 2010 Aug; 19(8):1561-7. PubMed ID: 20575712
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.
Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Domingo MC; Giguère JF; Piret J; Mwatha A; Mâsse B; Bergeron MG
Contraception; 2010 Jan; 81(1):79-85. PubMed ID: 20004278
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
11. A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.
Bakobaki JM; Lacey CJ; Bukenya MI; Nunn AJ; McCormack S; Byaruhanga RN; Okong P; Namukwaya SW; Grosskurth H; Whitworth JA
AIDS; 2005 Dec; 19(18):2149-56. PubMed ID: 16284465
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
Whitehead SJ; McLean C; Chaikummao S; Braunstein S; Utaivoravit W; van de Wijgert JH; Mock PA; Siraprapasiri T; Friedland BA; Kilmarx PH; Markowitz LE
PLoS One; 2011; 6(9):e14831. PubMed ID: 21915249
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
[TBL] [Abstract][Full Text] [Related]
14. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Giguere JF; Domingo MC; Piret J; Tsague L; Zekeng L; Mwatha A; Mâsse B; Bergeron MG
Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
[TBL] [Abstract][Full Text] [Related]
16. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
Braunstein S; van de Wijgert J
J Womens Health (Larchmt); 2005 Jun; 14(5):424-33. PubMed ID: 15989415
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
Joglekar N; Joshi S; Kakde M; Fang G; Cianciola M; Reynolds S; Mehendale S;
AIDS Care; 2007 Jul; 19(6):817-21. PubMed ID: 17573603
[TBL] [Abstract][Full Text] [Related]
18. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
[TBL] [Abstract][Full Text] [Related]
19. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
20. Microbicides: information, beliefs, and preferences for insertion.
Auslander BA; Perfect MM; Breitkopf DM; Succop PA; Rosenthal SL
J Womens Health (Larchmt); 2007 Dec; 16(10):1458-67. PubMed ID: 18062761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
